Lignans with inhibitory activity against NFAT transcription from Schisandra chinensis

Cited 22 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorI S Lee-
dc.contributor.authorHyeong Kyu Lee-
dc.contributor.authorN T Dat-
dc.contributor.authorM S Lee-
dc.contributor.authorJ W Kim-
dc.contributor.authorD S Na-
dc.contributor.authorY H Kim-
dc.date.accessioned2017-04-19T08:59:43Z-
dc.date.available2017-04-19T08:59:43Z-
dc.date.issued2003-
dc.identifier.issn0032-0943-
dc.identifier.uri10.1055/s-2003-37024ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/6067-
dc.description.abstractSeven lignans from Schisandra chinensis were investigated for their inhibitory activity on NFAT transcription. Both gomisin N (IC50: 1.33 ± 0.05 μM) and schisandrol A (IC50: 1.34 ± 0.05 μM) showed higher activity than gomisin E (IC50:4.73 ± 0.09 μM), schisandrin A (IC50: 7.23 ± 0.21 μM), schisandrin C (IC50: 7.54 ± 0.22 μM), benzoylisogomisin O (IC50: 11.06 ± 1.02 μM) and schisandrol B (IC50: 16.37 ± 1.00 μM).-
dc.publisherGeorg Thieme Verlag Kg-
dc.titleLignans with inhibitory activity against NFAT transcription from Schisandra chinensis-
dc.title.alternativeLignans with inhibitory activity against NFAT transcription from Schisandra chinensis-
dc.typeArticle-
dc.citation.titlePlanta Medica-
dc.citation.number1-
dc.citation.endPage64-
dc.citation.startPage63-
dc.citation.volume69-
dc.contributor.affiliatedAuthorHyeong Kyu Lee-
dc.contributor.alternativeName이임선-
dc.contributor.alternativeName이형규-
dc.contributor.alternativeNameDat-
dc.contributor.alternativeName이미선-
dc.contributor.alternativeName김정우-
dc.contributor.alternativeName나도선-
dc.contributor.alternativeName김영호-
dc.identifier.bibliographicCitationPlanta Medica, vol. 69, no. 1, pp. 63-64-
dc.identifier.doi10.1055/s-2003-37024-
dc.description.journalClassY-
Appears in Collections:
1. Journal Articles > Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.